Search Within

John Laurence Humm

Formats
  1. Journal Article (232)
  2. Meeting Abstract (180)
  3. Book Section (9)
  4. Conference Paper (8)
  5. Editorial (3)
  6. Review (3)
  7. Correspondence (1)
Groups
  1. Medical Physics (436)
  2. Radiology, Department of (313)
  3. Molecular Imaging and Therapy Service (282)
  4. GSK Faculty (232)
  5. Molecular Pharmacology and Chemistry Program Faculty (193)
  6. Sloan Kettering Institute Faculty (193)

More Groups

People
  1. Steven Larson (185)
  2. Pat Zanzonico (100)
  3. Heiko Schoder (96)
  4. Yusuf Erdi (57)
  5. Joseph O'Donoghue (56)
  6. Ronald Finn (56)

More People

Years
  1. 2025 (5)
  2. 2024 (12)
  3. 2023 (14)
  4. 2022 (21)
  5. 2021 (12)
  6. 2020 (10)

More Years

Publications
  1. Journal of Nuclear Medicine (114)
  2. Medical Physics (65)
  3. International Journal of Radiation Oncology, Biology, Physics (40)
  4. European Journal of Nuclear Medicine and Molecular Imaging (21)
  5. Journal of Clinical Oncology (17)
  6. Neuro-Oncology (15)

More Publications

Publishers
  1. Society of Nuclear Medicine (114)
  2. American Association of Physicists in Medicine (65)
  3. Elsevier Inc. (63)
  4. Springer (42)
  5. Oxford University Press (19)
  6. American Society of Clinical Oncology (17)

More Publishers

Results (436)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Determination of the treatment coverage of theragnostic (124)I-8H9 antibody to treat diffuse pontine glioma by convective enhance delivery
    Meeting Abstract

    Velo, A. F.; Larsen, A. G.; Humm, J.; Zanzonico, P.; Souweidane, M.; Pandit-Taskar, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Development of a semi-automatic platform for whole body tumor segmentation and radiomic feature extraction from 68Ga-DOTATATE PET/CT using TriDFusion (3DF)
    Meeting Abstract

    Krebs, S.; Lafontaine, D.; Bodei, L.; Mayerhoefer, M. E.; Humm, J.; Schöder, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Lesion dosimetry for [(177)Lu]Lu-PSMA-617 radiopharmaceutical therapy combined with stereotactic body radiotherapy in patients with oligometastatic castration-sensitive prostate cancer
    Journal Article

    Grkovski, M.; O'Donoghue, J. A.; Imber, B. S.; Andl, G.; Tu, C.; Lafontaine, D.; Schwartz, J.; Thor, M.; Zelefsky, M. J.; Humm, J. L.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Preoperative (18)F-FDG PET/CT and CT radiomics for identifying aggressive histopathological subtypes in early stage lung adenocarcinoma
    Journal Article

    Choi, W.; Liu, C. J.; Alam, S. R.; Oh, J. H.; Vaghjiani, R.; Humm, J.; Weber, W.; Adusumilli, P. S.; Deasy, J. O.; Lu, W.
    Computational and Structural Biotechnology Journal (2023)

    Fulltext@MSK | Save
  • Activation of STING in response to partial-tumor radiation exposure
    Journal Article

    Mathieu, M.; Budhu, S.; Nepali, P. R.; Russell, J.; Powell, S. N.; Humm, J.; Deasy, J. O.; Haimovitz-Friedman, A.
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • A pilot study of stereotactic body radiotherapy and (177)Lu-PSMA-617 for oligometastatic hormone sensitive prostate cancer
    Meeting Abstract

    Imber, B. S.; Bodei, L.; Humm, J.; Ionescu, A.; Wu, W.; Grkovski, M.; O'Donoghue, J.; Reddy, R. P.; Rimner, A.; Shasha, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Yttrium-90 activity quantification in PET/CT–guided biopsy specimens from colorectal hepatic metastases immediately after transarterial radioembolization using micro–CT and autoradiography
    Journal Article

    Naydenov, N.; Teplov, A.; Zirakchian, M. Z.; Ruan, S.; Chu, B. P.; Serencsits, B.; Iraca, M.; Talarico, O.; Miller, B.; Kunin, H.; more...
    Journal of Vascular and Interventional Radiology (2023)

    Fulltext@MSK | Save
  • The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): A regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
    Journal Article

    Mauguen, A.; Grewal, R. K.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J.; Haque, S.; Wong, B. Z. Y.; Ghossein, R. A.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Radioimmunoscintigraphy and pretreatment dosimetry of (131)I-omburtamab for planning treatment of leptomeningeal disease
    Journal Article

    Pandit-Taskar, N.; Grkovski, M.; Zanzonico, P. B.; Pentlow, K. S.; Modak, S.; Kramer, K.; Humm, J. L.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma
    Journal Article

    Tringale, K. R.; Wolden, S. L.; Karajannis, M.; Haque, S.; Pasquini, L.; Yildirim, O.; Rosenblum, M.; Benhamida, J. K.; Cheung, N. K.; Souweidane, M.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save